BATM Advanced Communications Ltd - Israel-based networking and medical technology company - says it has developed a new test for the rapid and comprehensive diagnosis of tuberculosis. Test takes two hours instead of several days with current methods. Clinical trials to start in second half of this year, fully funded by UN's Stop TB Partnership. Expects sales to begin next year.
Current stock price: 98.40 pence
Year-to-date change: up 5.8%
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


(Correcting that BATM Advanced Communications shares did not hit 12-month high on Monday and are 60% off the 12 month high.)


(Alliance News) - BATM Advanced Communications Ltd said on Monday subsidiary Telco Systems has partnered with London-based hardware and software compa...


(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.


(Sharecast News) - Telecommunications company BATM Advanced Communications' Telco Systems subsidiary has struck a partnership with industrial internet...


(Alliance News) - BATM Advanced Communications Ltd on Thursday said it is on-track to report a 2021 performance ahead of market expectations, fosterin...


(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.


(Sharecast News) - BATM Advanced Communications said annual earnings and revenue would beat expectations with momentum continuing in the new year.